Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
The Product will be manufactured at the company's facility in Bengaluru
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
The cognitively operated system is a mother patent invention, first launched in India
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS
Six engaging sessions focusing on Prevention of Kidney Diseases, Brain Stem Death Declaration, Deceased Donor Management, Prevention of Liver Diseases, Legal Aspects of Organ and Tissue Donation, Eye Donation and Corneal Transplant held as part of the Webinar
Subscribe To Our Newsletter & Stay Updated